{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:10:45Z","timestamp":1649182245348},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,5,4]]},"DOI":"10.1001\/jama.2021.2783","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T15:01:01Z","timestamp":1620140461000},"page":"1792","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer"],"prefix":"10.1001","volume":"325","author":[{"given":"Deep","family":"Chakrabarti","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, King George\u2019s Medical University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseem","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, King George\u2019s Medical University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, King George\u2019s Medical University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"jle210022r1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.2020.23370","article-title":"Effect of capecitabine maintenance therapy using lower dosage and higher frequency vs observation on disease-free survival among patients with early-stage triple-negative breast cancer who had received standard treatment: the SYSUCC-001 randomized clinical trial.","volume":"325","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"jle210022r2","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"22","key":"jle210022r3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy.","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"jle210022r4","unstructured":"BC Cancer Agency. Capecitabine. Accessed January 30, 2021. http:\/\/www.bccancer.bc.ca\/drug-database-site\/Drug Index\/Capecitabine_monograph.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2779556\/jama_chakrabarti_2021_le_210022_1620138052.42704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T15:01:05Z","timestamp":1620140465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2779556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":4,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.2783","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}